“5-Azacytidine treatment inhibits the development of lung cancer models via epigenetic reprogramming and activation of cellular pathways with anti-tumor activity” (2024) Medicine and Pharmacy Reports, 97(4), pp. 488–506. doi:10.15386/mpr-2777.